Merck KGaA (FRA:MRK) has been given a €125.00 ($147.06) price target by analysts at Oddo Bhf in a research report issued on Friday. The brokerage currently has a “buy” rating on the healthcare company’s stock.

A number of other research firms have also recently commented on MRK. S&P Global set a €110.00 ($129.41) price target on Merck KGaA and gave the stock a “buy” rating in a report on Thursday, August 3rd. Warburg Research set a €116.00 ($136.47) price target on Merck KGaA and gave the stock a “neutral” rating in a report on Thursday, August 3rd. Nord/LB set a €100.00 ($117.65) price target on Merck KGaA and gave the stock a “neutral” rating in a report on Thursday, August 3rd. Commerzbank Ag set a €109.00 ($128.24) price target on Merck KGaA and gave the stock a “neutral” rating in a report on Thursday, August 3rd. Finally, Berenberg Bank set a €110.00 ($129.41) price target on Merck KGaA and gave the stock a “neutral” rating in a report on Thursday, August 3rd. Thirteen equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of €109.17 ($128.44).

Merck KGaA (FRA MRK) traded down 0.77% on Friday, hitting €91.99. 1,206 shares of the company traded hands. Merck KGaA has a 1-year low of €89.00 and a 1-year high of €115.00. The firm has a market capitalization of €40.00 billion and a PE ratio of 23.98. The firm’s 50 day moving average price is €95.91 and its 200 day moving average price is €100.82.

COPYRIGHT VIOLATION NOTICE: This article was originally published by American Banking News and is the property of of American Banking News. If you are reading this article on another publication, it was illegally stolen and republished in violation of United States & international copyright and trademark law. The correct version of this article can be read at https://www.americanbankingnews.com/2017/10/27/oddo-bhf-analysts-give-merck-kgaa-mrk-a-125-00-price-target.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.